Leading the way to non-invasive neonatal therapies

ONY Biotech is a family-focused neonatology pharmaceutical company creating therapies that improve outcomes for premature babies and their families.

About us

For babies with respiratory distress syndrome, tomorrow is made possible by Infasurf® (calfactant).

Infasurf® (calfactant) helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.

Learn more

Latest News

Study Results are in on a Potential Non-Invasive Treatment for RDS

November 3, 2020

STUDY RESULTS ARE IN ON A POTENTIAL NON-INVASIVE TREATMENT FOR RDS, THE LEADING CAUSE OF DEATH IN PREMATURE BABIES...

ONY BIOTECH PREPARES FOR THE FUTURE

May 19, 2020

Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started...

Infasurf® (calfactant) Business Continuity Statement: COVID-19

March 18, 2020

To Our Customers, It has become clear in the past few weeks we are facing an unprecedented challenge whose...

All News